Literature DB >> 29027222

Alarmins and immunity.

Zhen Han1, Joost J Oppenheim1.   

Abstract

More than a decade has passed since the conceptualization of the "alarmin" hypothesis. The alarmin family has been expanding in terms of both number and the concept. It has recently become clear that alarmins play important roles as initiators and participants in a diverse range of physiological and pathophysiological processes such as host defense, regulation of gene expression, cellular homeostasis, wound healing, inflammation, allergy, autoimmunity, and oncogenesis. Here, we provide a general view on the participation of alarmins in the induction of innate and adaptive immune responses, as well as their contribution to tumor immunity. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  alarmin; damage-associated molecular pattern; dendritic cells; immune response; tumor immunity

Mesh:

Substances:

Year:  2017        PMID: 29027222      PMCID: PMC5699517          DOI: 10.1111/imr.12577

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  244 in total

1.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.

Authors:  Yong Qin; Suhendan Ekmekcioglu; Ping Liu; Lyn M Duncan; Gregory Lizée; Nancy Poindexter; Elizabeth A Grimm
Journal:  Mol Cancer Res       Date:  2011-09-27       Impact factor: 5.852

Review 3.  Harnessing the alarmin HMGN1 for anticancer therapy.

Authors:  De Yang; Michael Bustin; Joost J Oppenheim
Journal:  Immunotherapy       Date:  2015-11-16       Impact factor: 4.196

Review 4.  The dendritic cell-tumor cross-talk in cancer.

Authors:  Yuting Ma; Laetitia Aymeric; Clara Locher; Guido Kroemer; Laurence Zitvogel
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

5.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

7.  Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells.

Authors:  F Niyonsaba; A Someya; M Hirata; H Ogawa; I Nagaoka
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

8.  Discovery of five conserved beta -defensin gene clusters using a computational search strategy.

Authors:  Brian C Schutte; Joseph P Mitros; Jennifer A Bartlett; Jesse D Walters; Hong Peng Jia; Michael J Welsh; Thomas L Casavant; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

9.  Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.

Authors:  Kahori Kurosaka; Qian Chen; Felix Yarovinsky; Joost J Oppenheim; De Yang
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

10.  Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.

Authors:  Zhifang Zhang; Gregory Cherryholmes; Frances Chang; David M Rose; Ingrid Schraufstatter; John E Shively
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

View more
  103 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  HMGB1-Neutralizing IgM Antibody Is a Normal Component of Blood Plasma.

Authors:  Yajun Geng; Gnanasekar Munirathinam; Sunil Palani; Joseph E Ross; Bin Wang; Aoshuang Chen; Guoxing Zheng
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 3.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

4.  Structure, function, and evolution of Gga-AvBD11, the archetype of the structural avian-double-β-defensin family.

Authors:  Nicolas Guyot; Hervé Meudal; Sascha Trapp; Sophie Iochmann; Anne Silvestre; Guillaume Jousset; Valérie Labas; Pascale Reverdiau; Karine Loth; Virginie Hervé; Vincent Aucagne; Agnès F Delmas; Sophie Rehault-Godbert; Céline Landon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

5.  Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior.

Authors:  Matthew G Frank; Laura K Fonken; Samuel D Dolzani; Jessica L Annis; Philip H Siebler; Dominic Schmidt; Linda R Watkins; Steven F Maier; Christopher A Lowry
Journal:  Brain Behav Immun       Date:  2018-05-26       Impact factor: 7.217

Review 6.  How galectins have become multifunctional proteins.

Authors:  Gabriel García Caballero; Herbert Kaltner; Tanja J Kutzner; Anna-Kristin Ludwig; Joachim C Manning; Sebastian Schmidt; Fred Sinowatz; Hans-Joachim Gabius
Journal:  Histol Histopathol       Date:  2020-01-10       Impact factor: 2.303

7.  Impaired microcirculation function in COVID-19 and implications for potential therapies.

Authors:  Aleksandra Gąsecka; Krzysztof J Filipiak; Miłosz J Jaguszewski
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

Review 8.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?

Authors:  M H J van den Bosch
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

9.  Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab.

Authors:  Erminia Ridolo; Francesco Pucciarini; Maria Cristina Nizi; Eleni Makri; Paola Kihlgren; Lorenzo Panella; Cristoforo Incorvaia
Journal:  Hum Vaccin Immunother       Date:  2020-05-13       Impact factor: 3.452

10.  Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Sung Soo Ahn; Taejun Yoon; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.